Reference
Ogawa T, et al. Moderate renal dysfunction may not require a cisplatin dose reduction: A retrospective study of cancer patients with renal impairment. International Journal of Clinical Oncology 18: 977-982, No. 6, Dec 2013. Available from: URL: http://doi.org/10.1007/s10147-012-0481-x - Japan
Rights and permissions
About this article
Cite this article
Cisplatin. Reactions Weekly 1546, 71 (2015). https://doi.org/10.1007/s40278-015-9410-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-9410-x